In a major victory for cancer care, the Centers for Medicare & Medicaid Services (CMS) stated yesterday that it would not change its clinical trials coverage policy. The American Society of Clinical Oncology (ASCO) and others in the cancer community have been urging CMS to continue coverage after the agency issued a proposal July 17 that threatened Medicare beneficiaries’ access to clinical trials. [click link for full article]